Beijing Tide Pharmaceutical Co., Ltd   Report issue

For profit Phase 2
Founded: BEIJING China (1995)
Status: No NME R&D (1995)

Organization Overview

First Clinical Trial
2014
NCT02030769
First Marketed Drug
2021
colesevelam (welchol)
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

BEIJING TIDE PHARM | Beijing Tide Pharmaceutical Co., Ltd